Specialty Excipients for Pharmaceutical Liquid Dosage Form: Emerging Markets is a continuation of Kline's benchmark series of in-depth reports on the various end-use markets for excipients. The report series will cover the emerging markets in Brazil, China, and India. For the purpose of this research, liquids are defined as syrups, solutions, liquid ampoules, dispersions, semi-solids, and softgels.Specialty Excipients for Pharmaceutical Liquid Dosage Form: Emerging Markets

1. Chemicals
In-Depth Report Series
Specialty Excipients for Pharmaceutical
Liquid Dosage Form:
Emerging Markets
To Be Published 3rd Quarter 2013
Base Year: 2012
Regional Coverage Specialty Excipients for Pharmaceutical Liquid Dosage Form:
Emerging Markets is a continuation of Kline's benchmark series of
Brazil in-depth reports on the various end-use markets for excipients. The
report series will cover the emerging markets in Brazil, China, and
India
India. For the purpose of this research, liquids are defined as syrups,
China solutions, liquid ampoules, dispersions, semi-solids, and softgels.
Excipients included within this research are:
Antioxidants
Buffering Agents
Emulsifying Agents
Preservatives
Rheology Modifiers
Solvents
Sweetening Agents
An additional chapter on encapsulation technology is also included
within this report.
The base year for this program will be 2012 and will include forecasts
to the year 2017.
www.KlineGroup.com
Report #Y611I | © 2013 Kline & Company, Inc.

2. Specialty Excipients for Pharmaceutical Liquid Dosage Form:
Emerging Markets
Proposed Report Contents for Each Regional Report
Each regional volume will feature distinct and detailed analyses of seven major specialty excipient categories. Key industry
dynamics and trends will also be examined in each volume. Business profiles of leading and niche specialty excipient and delivery
technology suppliers will be provided for each region.
1. INTRODUCTION
Background information on the scope, methodology, and terminology used in the report.
2. EXECUTIVE SUMMARY
A concise overview of key report findings and market developments.
3. PHARMACEUTICAL INDUSTRY OVERVIEW
An overview of the pharmaceutical industry to provide context for specialty excipient usage.
4. ANTIOXIDANTS
For each specialty active (Chapter 4-10), the following information will be provided:
Market Overview
Pricing Analysis
Market Sizing
Competitive Structure
Market Share Analysis
Supplier Profiles
Market Forecast and Outlook
Key Market Drivers and Constraints
5. BUFFERING AGENTS/Ph ADJUSTERS
6. EMULSIFYING AGENTS
7. PRESERVATIVES
8. RHEOLOGY CONTROL
9. SOLVENTS
10. SWEETENING AGENTS
11. ENCAPSULATION TECHNOLOGY
Chapter 11 will provide a qualitative overview.
12 CONCLUSIONS AND STRATEGIC RECOMMENDATIONS
www.KlineGroup.com Report #Y611I | © 2013 Kline & Company, Inc.

3. Specialty Excipients for Pharmaceutical Liquid Dosage Form:
Emerging Markets
Key Benefits
Specialty Excipients for Pharmaceutical Liquid Dosage Form: Emerging Markets will provide subscribers with
comprehensive market intelligence on the emerging countries: Brazil, India, and China.
This report series will provide subscribers with the necessary customer, competitive, and business intelligence to
develop effective strategic business plans. Comprehensive data and the insight included will help facilitate the
efficient allocation of financial, marketing, and manufacturing resources necessary for future business
development.
This report series has been specifically designed to assist current and potential specialty excipient suppliers with:
Understanding of the market dynamics of in each region researched with detailed analyses of seven major
specialty excipient categories and more than 25 individual products
Highlights of regulatory issues and key trends to enable development of targeted sales and marketing strategies
to exploit high growth areas
Assessment of key technology trends and drivers in liquid delivery systems to support new product
development
Business profiles of selected leading and niche regional manufacturers and marketers of specialty excipients to
enable competitive benchmarking
Five-year overall business outlook and appraisal to help subscribers identify and exploit emerging business
opportunities
Key questions addressed in the research include:
How will these countries evolve from the demand and supply-side perspectives over the next five years?
What are the sales of specialty excipients in each region?
What are the growth opportunities for specialty excipients in each country?
How will customer expectations and purchasing criteria and practices change over the next five years in each
region?
How will future regional government regulations affect the current product landscape and the development of
new specialty excipients?
How can we compete successfully and profitably in these emerging markets?
Which suppliers are active in the market and which excipients are they supplying?
What are the average prices of various specialty excipients?
What is the forecast consumption from 2013 to 2017?
www.KlineGroup.com Report #Y611I | © 2013 Kline & Company, Inc.

4. Specialty Excipients for Pharmaceutical Liquid Dosage Form:
Emerging Markets
Methodology
Kline is unmatched in our ability to gather hard-to-get market and competitive intelligence with a high degree of
confidence. Kline’s market analysis approach places the principal emphasis on primary research techniques to ensure
that the foundation of business intelligence and insight is accurate, current, and reliable.
During the course of field research, Kline’s professional staff of industry experts will conduct in-depth discussions and
personal interviews with a wide range of knowledgeable industry participants and opinion leaders, including leading
manufacturers and marketers of pharmaceutical products; leading manufacturers, marketers, and distributors of
specialty excipients; and pertinent government agencies and trade associations.
This approach has proven to be the most effective and reliable approach to obtaining accurate market data, capturing
expert insights, and identifying business opportunities. Primary research will represent the bulk of our research efforts.
In addition, this analysis will be supplemented by secondary research drawn from the review of suppliers’ product
literature and price lists; a search of recent trade and technical literature; Internet sources; and analysis of statistical
data from government, industry, and trade associations and agencies.
Kline Credentials
Kline is a worldwide consulting and research firm dedicated to providing the kind of insights and knowledge that helps
companies find a clear path to success. The firm has served the management consulting and market research needs of
organizations in the chemicals, materials, energy, life sciences, and consumer products industries for over 50 years.
Our solutions have helped clients develop better ways to create and Recently published or in-progress research for the
profit from new business opportunities, respond to competitive and Chemicals and Healthcare industry includes:
economic threats, improve productivity, achieve sustainable growth,
and optimize performance. Kline provides clients with facts, Specialty Excipients in Oral Solid-Dosage-Form
forecasts, and recommendations based solidly on the realities of the Pharmaceuticals 2011: Database Analysis
market.
The Specialty Excipient Market for Oral Solid-
Dosage-Form Pharmaceuticals Global Series
Kline’s research and consulting services extend across the entire
chemical and pharmaceutical industry value chain. We have been OTC Drugs: U.S. Competitor Cost Structures
tracking and analyzing the U.S. and international markets for 2009
pharmaceuticals and pharmaceutical actives, excipients, and
U.S. Retailers' Perceptions of OTC Drug
specialty ingredients for more than 20 years. In addition to our
Marketers 2008
resources in the specialty chemicals sector, the members of our
Healthcare practice have a thorough understanding of the markets Nonprescription Drugs USA 2008
for pharmaceutical products in the prescription and OTC segments. Rx-to-OTC Switch Strategies USA
Our market research reports and services are designed to provide U.S. Consumers' Perceptions of OTC Drugs 2007
subscribers with a deeper understanding of their markets, an outlook
for their business, and accurate information about their competitors. Our clients tell us they often use Kline’s market
research to validate their own internal analysis, and many clients rely on Kline reports as their most critical source of
information.
For more information about this study or Kline's other services, e-mail us at sales@klinegroup.com, visit our website at
www.KlineGroup.com, or contact us at any of our regional offices listed below.
North America Latin America Europe China India Japan
+1-973-435-3407 +55-11-3079-0792 +32-2-770-4740 +86-21-5292-5353 +91-124-4546-100 +81-3-3242-6277
www.KlineGroup.com Report #Y611I | © 2013 Kline & Company, Inc.